Skip to main content
HYDROGEN STUDIESPOWERED BY ECHO WATER

Silicon Agent with Hydrogen and Intestinal Injury in Mice

Si-based agent alleviated small bowel ischemia-reperfusion injury through antioxidant effects

Research hubs: Digestive System

This research was done in animals. Results in animals often don't carry over to people.

Scientific visualization of hydrogen therapy research for Si-based agent alleviated small bowel ischemia-reperfusion injury through antioxidant effects
Evidence type
Animal study (mouse)
Authors
Masato Shimada, Yoshihisa Koyama, Yuki Kobayashi, Yasunari Matsumoto, Hikaru Kobayashi, Shoichi Shimada
Journal
Scientific Reports
Year
2024
Study Type
Mouse
Delivery
Gas (Sustained Release)
Dose
oral administration of Si-based agent
Outcome
Positive
Peer Reviewed
Yes
Cited by
12 (OpenAlex, as of November 2026)
Country
Japan

TL;DR

A silicon-based antioxidant treatment reduces damage and cell death in the intestines caused by blood flow issues in mice.

Key Finding

A silicon-based agent that generates hydrogen in the intestinal tract reduced oxidative stress and cell death in a mouse model of small bowel ischemia-reperfusion injury while preserving the intestinal mucosal layer.

Summary

Researchers tested a silicon-based compound that produces hydrogen gas in the intestines to see if it could protect against ischemia-reperfusion injury—damage that occurs when blood flow to the small intestine is cut off and then restored. In mice, the treatment reduced cell damage by lowering oxidative stress (harmful chemical reactions) and preserved the protective lining of the intestine better than no treatment.

Practical Takeaway

This is early-stage research in mice only, so findings cannot yet be applied to humans. The study suggests hydrogen-generating compounds may eventually help prevent intestinal damage during transplantation, but much more research—including human trials—would be needed before any clinical use.

Abstract (excerpt)

The progression of small bowel ischemia-reperfusion (IR) injury causes cells in the intestinal tract to undergo necrosis, necessitating surgical resection, which may result in loss of intestinal function. Therefore, developing therapeutic agents that can prevent IR injury at early stages…

Read the full abstract on PubMed